Nortech Systems earnings release, May 13, 2026

Nortech Systems Inc (NSYS) · Form 8-K, Item 2.02 · Filed · SEC filing

Exhibit

99.1

Nortech

Systems Reports First Quarter Results

MINNEAPOLIS – May 13, 2026 – Nortech Systems Incorporated (Nasdaq: NSYS) (“Nortech” or the “Company”), a leading provider of engineering and manufacturing solutions for complex electromedical and electromechanical products serving the medical imaging, medical device, industrial, and aerospace & defense markets, reported financial results for the first quarter ended March 31, 2026.

2026

Q1 Highlights:

Management

Commentary

“Nortech delivered another quarter of operational and financial progress, marking our fourth consecutive period of encouraging operating and EBITDA results reflecting the positive execution of our strategic restructuring initiatives. We are seeing continued improvements in gross margins, manufacturing efficiency, and world-class quality metrics reflect the disciplined execution of our long-term strategy.

We are also excited to see our new Senior Vice President of Global Operations, Andrew Walko, stepping into his role to lead our global team and having an immediate and encouraging impact,” said President & CEO, Jay D. Miller.

“Our growing customer backlog, combined with the successful transfer of key programs to our optimized facilities, is strengthening the foundation for sustained performance improvement. Our Bemidji facility continues to make significant progress serving our customers in the Aerospace and Defense segment. Aerospace and Defense is historically our smallest customer segment, yet it continues to grow at a steady pace becoming an increasingly important part of our customer mix. The continued growth of the backlog will provide a tailwind for the Company into the second half of the year. With the closure of our new debt financing in March, and our strong North American and Asian footprint, we believe we are well-positioned to support customers pursuing nearshore manufacturing strategies. I am grateful for the hard work of our employees across the globe, and we remain optimistic about the opportunities ahead as we continue to execute our strategy in 2026 and beyond,” Miller said.

Summary

Financial Information

The following table provides summary financial information comparing the first quarter 2026 (“Q1 2026”) financial results to the same quarter in 2025 (“Q1 2025”).

Conference

Call

The

Company will hold a live conference call and webcast at 3:30 p.m. central time on Thursday, May 14, to discuss the Company’s 2026 first quarter results. The call will be hosted by Jay D. Miller, Chief Executive Officer and President and Andrew D. C. LaFrence, Chief

Financial Officer and Senior Vice President of Finance. To access the live audio conference call, US participants may call 888-506-0062 and international participants may call 973-528-0011. Participant Access Code: 361581. Participants may also access the call via webcast at: https://www.webcaster5.com/Webcast/Page/2814/53855.

###

About

Nortech Systems Incorporated

Nortech

Systems is a leading provider of design and manufacturing solutions for complex electromedical devices, electromechanical systems, assemblies, and components. Nortech primarily serves the medical imaging, medical device, aerospace & defense, and industrial markets. Its design services span concept development to commercial design, and include medical device, software, electrical, mechanical, and biomedical engineering. Its manufacturing and supply chain capabilities are vertically integrated around wire, cable, and interconnect assemblies, printed circuit board assemblies, as well as system-level assembly, integration, and final test. Headquartered in Maple Grove, Minn.,

Nortech currently has six manufacturing locations and design centers across the U.S., Latin America, and Asia. Nortech Systems is traded on the NASDAQ Stock Market under the symbol NSYS. Nortech’s website is www.nortechsys.com.

Forward-Looking

Statements

Financial statements

Income Statement (in thousands)

Q1 2026Q1 2025% Change
Net sales30,31626,89512.7%
Gross profit4,7023,07852.8%
Operating expenses4,6554,691-0.8%
Net loss-34-1,316-97.4%
EBITDA350-1,266-127.6%
Adjusted EBITDA350-1,000-135.0%

Income Statement

THREE MONTHS ENDED — (IN THOUSANDS, EXCEPT SHARE AND PER SHARE DATA)

THREE MONTHS ENDED – MARCH 31, – 2026THREE MONTHS ENDED – MARCH 31, – 2025
Net sales30,31626,895
Cost of goods sold25,61423,817
Gross profit4,7023,078
Operating expenses:Selling1,3311,184
Operating expenses:General and administrative3,0142,915
Operating expenses:Research and development310326
Operating expenses:Restructuring charges266
Operating expenses:Total operating expenses4,6554,691
Operating expenses:Income (loss) from operations47-1,613
Other expense:Interest expense, net-256-214
Other expense:Loss before income taxes-209-1,827
Other expense:Income tax benefit-175-511
Other expense:Net loss-34-1,316
Net loss per common share:Basic (in dollars per share)-0.01-0.48
Net loss per common share:Weighted average number of common shares outstanding - basic (in shares)2,786,1342,760,929
Net loss per common share:Diluted (in dollars per share)-0.01-0.48
Net loss per common share:Weighted average number of common shares outstanding - diluted (in shares)2,786,1342,760,929
Other comprehensive income (loss)Foreign currency translation696
Other comprehensive income (loss)Comprehensive income (loss), net of tax35-1,310

Income Statement

Last Twelve Months (“LTM”) Ended in Quarter (in millions)

Last Twelve Months (“LTM”) Ended in Quarter – Q1 2023Last Twelve Months (“LTM”) Ended in Quarter – Q2 2023Last Twelve Months (“LTM”) Ended in Quarter – Q3 2023Last Twelve Months (“LTM”) Ended in Quarter – Q4 2023Last Twelve Months (“LTM”) Ended in Quarter – Q1 2024Last Twelve Months (“LTM”) Ended in Quarter – Q2 2024Last Twelve Months (“LTM”) Ended in Quarter – Q3 2024Last Twelve Months (“LTM”) Ended in Quarter – Q4 2024Last Twelve Months (“LTM”) Ended in Quarter – Q1 2025Last Twelve Months (“LTM”) Ended in Quarter – Q2 2025Last Twelve Months (“LTM”) Ended in Quarter – Q3 2025Last Twelve Months (“LTM”) Ended in Quarter – Q4 2025Last Twelve Months (“LTM”) Ended in Quarter – Q1 2026
Net Sales138.3140.8138.9139.3138.7137.5135.6128.1120.8117.6116.7118.4121.8
Gross Profit $ - Adjusted21.922.421.423.123.122.220.716.714.414.615.81819.6
Gross Margin % - Adjusted15.8%15.9%15.4%16.6%16.6%16.1%15.3%13.1%11.9%12.4%13.5%15.2%16.1%
EBITDA - Adjusted6.76.8688.17.35.92.1-0.5-0.40.72.53.9

Balance Sheet

MARCH 31, 2026 — (IN THOUSANDS, EXCEPT SHARE DATA)

MARCH 31, 2026DECEMBER 31, 2025
Current assets:Cash1,9641,655
Current assets:Restricted cash244
Current assets:Accounts receivable, less allowance for credit losses of $205 and $161, respectively17,82316,998
Current assets:Inventories, net23,56120,695
Current assets:Contract assets16,01015,184
Current assets:Prepaid assets and other assets1,0711,618
Current assets:Total current assets60,67356,150
Current assets:Property and equipment, net5,0775,203
Current assets:Operating lease assets, net6,7207,016
Current assets:Deferred tax assets3,7533,394
Current assets:Other intangible assets, net151156
Current assets:Deferred line of credit issuance costs266
Current assets:Total assets76,64071,919
Current liabilities:Lines of credit7,4857,000
Current liabilities:Current portion of term loan433
Current liabilities:Accounts payable14,64512,809
Current liabilities:Accrued payroll and commissions2,7081,822
Current liabilities:Customer deposits4,6725,386
Current liabilities:Current portion of operating leases1,3091,332
Current liabilities:Current portion of finance lease obligations259274
Current liabilities:Other accrued liabilities1,4871,221
Current liabilities:Total current liabilities32,99829,844
Long-term liabilities:Term loan1,743
Long-term liabilities:Long-term operating lease obligations6,1866,476
Long-term liabilities:Long-term finance lease obligations577626
Long-term liabilities:Other long-term liabilities428426
Long-term liabilities:Total long-term liabilities8,9347,528
Long-term liabilities:Total liabilities41,93237,372
Shareholders’ equity:Preferred stock, $1 par value; 1,000,000 shares authorized; 250,000 shares issued and outstanding250250
Shareholders’ equity:Common stock - $0.01 par value; 9,000,000 shares authorized; 2,786,134 and 2,786,134 shares issued and outstanding, respectively2828
Shareholders’ equity:Additional paid-in capital17,98117,855
Shareholders’ equity:Accumulated other comprehensive loss-640-709
Shareholders’ equity:Retained earnings17,08917,123
Shareholders’ equity:Total shareholders’ equity34,70834,547
Shareholders’ equity:Total liabilities and shareholders’ equity76,64071,919

Cash Flow

THREE MONTHS ENDED MARCH 31, — (IN THOUSANDS) (in thousands)

THREE MONTHS ENDED MARCH 31, – 2026THREE MONTHS ENDED MARCH 31, – 2025
CASH FLOWS FROM OPERATING ACTIVITIESNet loss-34-1,316
Adjustments to reconcile net loss to net cash used in operating activities:Depreciation and amortization303347
Adjustments to reconcile net loss to net cash used in operating activities:Compensation on stock-based awards126118
Full release

T his press release contains forward-looking statements made pursuant to the safe harbor provision of the Private Securities Litigation Reform

Act of 1995 including without limitation statements regarding future financial results including increased gross margin, our ability to generate positive EBITDA, increased plant utilization and manufacturing efficiency, growth of our backlog, continuing improvement of quality metrics, success in moving production from on facility to another Company owned facility, nearshoring as a strategic advantage, successful execution of our long-term strategy, our enhanced competitiveness in aerospace, defense, and other high-reliability markets, effects of restructuring and consolidating manufacturing facilities, sustained long-term health and growth, and optimism about customer pipeline. While this release is based on management’s best judgment and current expectations, actual results may differ materially from those expressed or implied and involve a number of risks and uncertainties. Important factors that could cause actual results to differ materially from the forward-looking statements include, without limitation: (1) commodity cost increases coupled with challenges in raising prices and/or customer pressure to reduce prices; (2) supply chain disruptions leading to shortages of critical components;

(3) volatility in market conditions which may affect demand for the Company’s products; (4) increased competition and/or reduced demand; (5) changes in the reliability and efficiency of operating facilities or those of third parties; (6) risks related to the availability of labor; (7) the unanticipated loss of any key member of senior management; (8) geopolitical, economic, financial and business conditions including changing tariff environment; (9) the Company’s ability to steadily improve manufacturing output and product quality;... (truncated)arkets and our financial condition; (11) challenges with customers with respect to moving production from one facility to another Company-owned facility or (12) financing cost increases and continued availability. Some of the above-mentioned factors are described in further detail in the section entitled “Risk Factors” in our annual and quarterly reports, as applicable. You should assume the information appearing in this document is accurate only as of the date hereof, or as otherwise specified, as our business, financial condition, results of operations and prospects may have changed since such date. Except as required by applicable law, including the securities laws of the United States and the rules and regulations of the United States Securities and Exchange Commission, we undertake no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events or otherwise, to refle ct actual results or changes in factors or assumptions affecting such forward-looking statements.

Reconciliation of Generally Accepted Accounting Principles (“GAAP”) Measures to Non-GAAP Financial Measure

EBITDA is a non-GAAP financial measure used by management that we believe provides useful information to investors because it reflects ongoing performance excluding certain non-recurring items during comparable periods and facilitates comparisons between peer companies since interest, taxes, depreciation, and amortization can differ greatly between different organizations as a result of differing capital structures and tax strategies. EBITDA is defined as net income (loss) plus interest expense, plus income tax expense plus depreciation expense and amortization expense. EBITDA should be considered in addition to, not as a substitute for, or superior to, financial measures calculated in accordance with GAAP. Adjusted EBITDA reflects the impact of restructuring and non-recurring items. EBITDA and Adjusted EBITDA are not a measurement of our financial performance under GAAP and should not be considered an alternative to net sales or net income (loss), as applicable, or any other performance measures derived in accordance with GAAP and may not be comparable to other similarly titled measures of other businesses. EBITDA and Adjusted EBITDA have limitations as an analytical metric, and you should not consider it in isolation or as a substitute for analysis of our operating results as reported under GAAP.

NORTECH

SYSTEMS INCORPORATED AND SUBSIDIARIES

From SEC EDGAR. Analysis by Pear Digitals from the filing alone. Not investment advice. · Nortech Systems earnings · Latest earnings · Markdown

Screener

Plans

Premium and Pro coming soon.

Log in

New here?

Join the waitlist

Pear FMV opens to everyone soon. We'll email you when it does.